Europe Travel Vaccines Market Forecast to 2028

Report Code : BMIRE00025498 | Region : Europe | Industry : Pharmaceuticals | Published Date : 28/Jul/2022
Europe Travel Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Hepatitis A, Hepatitis B, Meningococcal Vaccines, and Others) and Application (Domestic Travel and Outbound Travel)

The travel vaccines market in Europe is expected to grow from US$ 995.47 million in 2021 to US$ 1,885.56 million by 2028; it is estimated to grow at a CAGR of 9.6% from 2021 to 2028.

Hepatitis, HIV/AIDS, human papillomavirus (HPV), meningococcal disease, typhoid, and yellow fever are among the various chronic diseases detected across the region. Similarly, in 2021, the Centers for Disease Control and Prevention (CDC) launched the global immunization strategic framework 2021–2030. The framework provides a plan to vaccinate against vaccine-preventable diseases (VPDs), such as hepatitis A and B. Moreover, there are different vaccine routines for travelers proposed by WHO to prevent the spread of deadly infectious diseases. The vaccine routine includes routine vaccines for review before traveling, vaccines for certain destinations, and vaccines demanded by certain countries. In most cases, booster doses of routine vaccines are required if people have not followed the regular schedule. Such initiatives by WHO and CDC enhance the vaccine demand, thereby driving its market growth. On the other hand, the COVID–19 outbreak threatened public health. Various emergency actions were initiated during the pandemic, of which the COVAX initiative was aggressively enacted. Vaccination against COVID–19 was mandatory for people worldwide. Governments in every region mandated vaccines for people traveling within and outside countries. The COVID-19 pandemic contributed significantly to travel vaccines. Thus, the factors mentioned above are driving the market growth.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe travel vaccines market . The Europe travel vaccines market is expected to grow at a good CAGR during the forecast period.

Europe Travel Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Europe Travel Vaccines Market Segmentation

Europe travel vaccines market is segmented into product, application, and country. The Europe travel vaccines market, by product, is segmented into hepatitis A, hepatitis B, meningococcal vaccines, and others. In 2021, the others segment held the largest share of the market. The Europe travel vaccines market, by application, is segmented into domestic travel and outbound travel. In 2021, the outbound travel segment held the largest share of the market. Based on country, the Europe travel vaccines market is segmented into France, Germany, Italy, the UK, Russia, and the Rest of Europe.

Abbott; Dynavax Technologies; Emergent BioSolutions Inc.; GlaxoSmithKline plc; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; Sanofi; and Valneva SE are among the leading companies in the travel vaccines market in the region.

The List of Companies - Europe Travel Vaccines Market

● Abbott

● Dynavax Technologies

● Emergent BioSolutions Inc.

● GlaxoSmithKline plc

● Merck & Co., Inc.

● Novartis AG

● Pfizer Inc.

● Sanofi

● Valneva SE.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Travel Vaccines Market – By Product

1.3.2 Europe Travel Vaccines Market – By Application

1.3.3 Europe Travel Vaccines Market – By Country

2. Europe Travel Vaccines Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Travel Vaccines Market– Market Landscape

4.1 Overview

4.2 Europe PEST Analysis

4.3 Expert Opinion

5. Europe Travel Vaccines Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Significant Rise in Travel and Tourism

5.1.2 Growing Incidences of Infectious Diseases

5.2 Market Restraints

5.2.1 High Cost of Travel Vaccines

5.3 Market Opportunities

5.3.1 Awareness Regarding Vaccines

5.4 Future Trends

5.4.1 Significant Demand for Vaccines

5.5 Impact Analysis

6. Travel Vaccines Market – Europe Analysis

6.1 Europe Travel Vaccines Marker Revenue Forecast and Analysis

7. Europe Travel Vaccines Market Analysis – By Product

7.1 Overview

7.2 Europe Travel Vaccines Market Revenue Share, by Product (2021 and 2028)

7.3 Hepatitis A

7.3.1 Overview

7.3.2 Hepatitis A: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

7.4 Hepatitis B

7.4.1 Overview

7.4.2 Hepatitis B: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

7.5 Meningococcal Vaccines

7.5.1 Overview

7.5.2 Meningococcal Vaccines: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

8. Europe Travel Vaccines Market Analysis – By Application

8.1 Overview

8.2 Europe Travel Vaccines Market Revenue Share, by Application (2021 and 2028)

8.3 Domestic Travel

8.3.1 Overview

8.3.2 Domestic Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

8.4 Outbound Travel

8.4.1 Overview

8.4.2 Outbound Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

9. Europe Travel Vaccines Market – Country Analysis

9.1 Overview

9.1.1 Europe: Travel Vaccines Market, by Country, 2020 & 2028 (%)

9.1.1.1 UK: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.1.1 UK: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.1.2 UK: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.1.3 UK: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

9.1.1.2 Germany: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.2.1 Germany: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.2.2 Germany: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.2.3 Germany: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

9.1.1.3 France: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.3.1 France: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.3.2 France: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.3.3 France: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

9.1.1.4 Italy: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.4.1 Italy: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.4.2 Italy: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.4.3 Italy: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

9.1.1.5 Spain: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.5.1 Spain: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.5.2 Spain: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.5.3 Spain: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

9.1.1.6 Rest of Europe: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.6.1 Rest of Europe: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.6.2 Rest of Europe: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.6.3 Rest of Europe: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

10. Travel Vaccines Market–Industry Landscape

10.1 Overview

10.2 Growth Strategies in the Travel Vaccines Market, (%)

10.3 Organic Developments

10.3.1 Overview

10.4 Inorganic Developments

10.4.1 Overview

11. Company Profiles

11.1 GlaxoSmithKline plc.

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Merck & Co., Inc.

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Sanofi

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Novartis AG

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Pfizer Inc.

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Dynavax Technologies

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Emergent BioSolutions Inc.

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Abbott

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 Valneva SE.

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

12. Appendix

12.1 About the Insight Partners

12.2 Glossary of Terms

LIST OF TABLES.

Table 1. UK: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 2. UK: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 3. Germany: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 4. Germany: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 5. France: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 6. France: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 7. Italy: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 8. Italy: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 9. Spain: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 10. Spain: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 11. Rest of Europe: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 12. Rest of Europe: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 13. Organic Developments Done by Companies

Table 14. Inorganic Developments Done by Companies

Table 15. Glossary of Terms, Europe Travel vaccines Market

The List of Companies - Europe Travel Vaccines Market

● Abbott

● Dynavax Technologies

● Emergent BioSolutions Inc.

● GlaxoSmithKline plc

● Merck & Co., Inc.

● Novartis AG

● Pfizer Inc.

● Sanofi

● Valneva SE.

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Automotive Backing Plate market forecast.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in North America Automotive Backing Plate market forecast, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth North America market trends and outlook coupled with the factors driving the automotive backing plate market, as well as those hindering it.

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Europe Travel Vaccines Market Forecast to 2028 )
  • Single User Price $3,000$2,400
  • Site Price $4,000$3,200
  • Enterprise Price $5,000$4,000
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry